Evidence-based Guidelines for Mental, Neurological, and Substance Use Disorders in Low- and Middle-income Countries: Summary of WHO Recommendations

Chisholm D . Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis. Epilepsia. 2005; 46(5):751-9. DOI: 10.1111/j.1528-1167.2005.52704.x. View

Chisholm D, Flisher A, Lund C, Patel V, Saxena S, Thornicroft G . Scale up services for mental disorders: a call for action. Lancet. 2007; 370(9594):1241-52. DOI: 10.1016/S0140-6736(07)61242-2. View

Engel Jr J . A practical guide for routine EEG studies in epilepsy. J Clin Neurophysiol. 1984; 1(2):109-42. DOI: 10.1097/00004691-198404000-00001. View

Saraceno B, van Ommeren M, Batniji R, Cohen A, Gureje O, Mahoney J . Barriers to improvement of mental health services in low-income and middle-income countries. Lancet. 2007; 370(9593):1164-74. DOI: 10.1016/S0140-6736(07)61263-X. View

Collins P, Patel V, Joestl S, March D, Insel T, Daar A . Grand challenges in global mental health. Nature. 2011; 475(7354):27-30. PMC: 3173804. DOI: 10.1038/475027a. View

Fowle A, Binnie C . Uses and abuses of the EEG in epilepsy. Epilepsia. 2000; 41 Suppl 3:S10-8. DOI: 10.1111/j.1528-1157.2000.tb01529.x. View

Tansella M, Thornicroft G . Implementation science: understanding the translation of evidence into practice. Br J Psychiatry. 2009; 195(4):283-5. DOI: 10.1192/bjp.bp.109.065565. View

Lejoyeux M, Huet F, Claudon M, Fichelle A, Casalino E, Lequen V . Characteristics of suicide attempts preceded by alcohol consumption. Arch Suicide Res. 2008; 12(1):30-8. DOI: 10.1080/13811110701800699. View

Patel V, Araya R, Chatterjee S, Chisholm D, Cohen A, de Silva M . Treatment and prevention of mental disorders in low-income and middle-income countries. Lancet. 2007; 370(9591):991-1005. DOI: 10.1016/S0140-6736(07)61240-9. View

10.

Denis C, Lavie E, Fatseas M, Auriacombe M . Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. Cochrane Database Syst Rev. 2006; (3):CD005336. DOI: 10.1002/14651858.CD005336.pub2. View

11.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G . A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Health Technol Assess. 2006; 10(23):iii-iv, xiii-146. DOI: 10.3310/hta10230. View

12.

Benbadis S, Tatum W . Overintepretation of EEGs and misdiagnosis of epilepsy. J Clin Neurophysiol. 2003; 20(1):42-4. DOI: 10.1097/00004691-200302000-00005. View

13.

Jacob K, Sharan P, Mirza I, Garrido-Cumbrera M, Seedat S, Mari J . Mental health systems in countries: where are we now?. Lancet. 2007; 370(9592):1061-77. DOI: 10.1016/S0140-6736(07)61241-0. View

14.

Weinmann S, Koesters M, Becker T . Effects of implementation of psychiatric guidelines on provider performance and patient outcome: systematic review. Acta Psychiatr Scand. 2007; 115(6):420-33. DOI: 10.1111/j.1600-0447.2007.01016.x. View

15.

Saxena S, Thornicroft G, Knapp M, Whiteford H . Resources for mental health: scarcity, inequity, and inefficiency. Lancet. 2007; 370(9590):878-89. DOI: 10.1016/S0140-6736(07)61239-2. View

16.

Barbui C, Dua T, van Ommeren M, Yasamy M, Fleischmann A, Clark N . Challenges in developing evidence-based recommendations using the GRADE approach: the case of mental, neurological, and substance use disorders. PLoS Med. 2010; 7(8). PMC: 2930877. DOI: 10.1371/journal.pmed.1000322. View

17.

Grimshaw J, Thomas R, MacLennan G, Fraser C, Ramsay C, Vale L . Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004; 8(6):iii-iv, 1-72. DOI: 10.3310/hta8060. View

18.

Chisholm D, Sanderson K, Ayuso-Mateos J, Saxena S . Reducing the global burden of depression: population-level analysis of intervention cost-effectiveness in 14 world regions. Br J Psychiatry. 2004; 184:393-403. DOI: 10.1192/bjp.184.5.393. View

19.

Kirsch I, Deacon B, Huedo-Medina T, Scoboria A, Moore T, Johnson B . Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008; 5(2):e45. PMC: 2253608. DOI: 10.1371/journal.pmed.0050045. View

20.

Ghuman J, Eugene Arnold L, Anthony B . Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice. J Child Adolesc Psychopharmacol. 2008; 18(5):413-47. PMC: 2935821. DOI: 10.1089/cap.2008.022. View